• Skip to main content
  • Skip to primary sidebar

Gold Coast Health & Knowledge Precinct

Transform with us

  • Home
  • About Us
    • Strategic Plan
    • Partners
      • City of Gold Coast
      • Griffith University
      • Gold Coast Health
      • Economic Development Queensland
      • Gold Coast Private Hospital
      • Cohort
      • Southport Sharks
    • Our people
    • Precinct Office
    • Map
    • Contact Us
  • Do Business
    • Investment Incentives
  • Live & Play
    • Australia’s Gold Coast
    • Residential – Smith Collective
    • Lifestyle – Retail and Recreation
  • Work & Study
  • Projects
    • Projects Overview
    • ADaPT
    • Clinical Entrepreneurship Change Agents Program
    • NeuTex Image-guided Surgery and Robotics Training Centre
  • Research
    • Overview
      • Additive Manufacturing
      • Biotechnologies
    • Research Institutes and Centres
    • Precinct experts
    • Research Equipment & Facilities
    • Clinical Trials
    • Health and medical training and conference hub
  • News
    • Latest News
    • Newsletter
    • Media
    • Video Channel
  • 中文
    • English
    • 中文
You are here: Home / News

News

Filed Under: BUSINESS, HEALTH, TECHNOLOGY Tagged With: Griffith University, healthtech, LuminaX

Griffith University team win top prize at 2023 LuminaX HealthTech Accelerator

After 14 weeks, 20 workshops, 300 hours of mentoring with 30+ mentors and a whole lot of support, 10 gamechanging healthtech startups hit the stage to pitch their businesses in front of more than 200 members of the GCHKP innovation ecosystem at LuminaX 2023 Demo Night.

And from an impressive lineup of commercial concepts to improve patient safety, provide VR treatment for complex mental health conditions, streamline nurse recruitment, revolutionise treatment for children with lower limb deformities and more, a trio of Griffith University researchers were named Startup of the Year for YourTrack, a neurodevelopmental assessment tool for children needing developmental support.

LuminaX Director Dren Xerxa with the YourTrack team: Professor Dianne Shanley, Dr Erinn Hawkins and Dr Wei Lui

Backed by extensive research and with a vision to be powered by AI, YourTrack was developed to track and triage children aged 0-17 years who have developmental concerns. The technology puts neurodevelopmental assessment in the hands of everyday health providers such as GPs and nurses, starting assessment and support earlier, rather than having to wait to rely on specialist paediatricians to assess vulnerable children who are falling behind.

Other clinical assessment tools are largely applicable to young children, but the YourTrack system works for children and adolescents while also providing a greater degree of insight into the extent of a child’s developmental delays.

YourTrack harnesses the power of local health providers so that kids can be ‘diagnosed faster, supported sooner’ and is set to do just that through the commercial acceleration the team achieved through LuminaX.

Professor Dianne Shanley, a clinical psychologist and prominent expert in health service delivery, says the team is excited to have a path towards sharing commercial proceeds from their clinical assessment tool with the community who helped design it.

“The LuminaX journey has been one of the most memorable and engaging learning experiences and we’re so thrilled and surprised to receive the award,” says Professor Shanley.

“The mentoring has helped us to develop a commercial pathway for organisations across the country to access what we’ve co-designed through our research.”

YourTrack Research Manager Dr Wei Liu says LuminaX was invaluable in honing the team’s understanding of customers.

“We reformed our pitch deck, developed our business model and “go to market” strategies, as well as rebranded our logo and website,” says Dr Liu.

“The biggest lesson I learned is to spend time with customers to understand what they want, not what we think they want. Then we present our products as either solving their problems or fulfilling their needs instead of “hard selling” what we have created. 

“We’ve successfully attracted several new customers by using this method.” 

Dr Erinn Hawkins, who co-developed part of the tracking system with a team in Bangladesh, says they now feel confident to work with partners to make YourTrack Developmental Tracking Systems the most trusted developmental assessment system on the market.

“We believe we can now translate our research outcomes into a commercial product that will help us reach and support the more than one million Australian children with developmental vulnerabilities,” she says.

Alignus team aid surgeries during LuminaX
Dr Martina Barzan delivers the Alignus pitch

For the second Griffith University team in the program, biomedical engineer Dr Martina Barzan and clinical researcher Associate Professor Chris Carty of Alignus, LuminaX provided a boost towards the commercial rollout of their world-leading surgery simulation technology to aid orthopaedic surgeries, starting with paediatric patients.

Even during the busy LuminaX program, Dr Barzan worked with surgeons to plan and execute two complex orthopaedic surgeries, taking the total of successful procedures performed with their products to almost 30.

“[In LuminaX] we had access to industry leaders in product development, brand identity and financial modelling, and with the support of the expert LuminaX team, we were able to prepare a compelling pitch that is already attracting investment interest, “says Associate Professor Carty.

“Our next step is to partner with like-minded investors to secure regulatory approval for Alignus products by the end of 2024.”

LuminaX Fan Fave winner optimises nurse recruitment

For nurse Anna Lumb, relocating to Brisbane and searching for the right job sparked her idea to create a dedicated careers marketplace for what she call’s Australia’s almost half-a-million strong “nurseforce”.

Anna Lumb of Nursify won the Fans Fave Award

Struck by the irony of working in Australia’s most sought-after profession but being unable to connect directly with hospitals to find the right role, Nursify was born. One of six female founders to pitch during the slick Demo Night at Miami Marketta, Lumb was judged ‘Fans Fave’.

LuminaX is a 14-week program that validates and commercialises selected early-stage, high-growth activities applying tech or AI solutions to healthcare, medtech and wellness. Developed and delivered by Cohort Innovation Space, it has the support of major partners the Queensland Government (through Economic Development Queensland and Advance Queensland) and City of Gold Coast.

Griffith University, Mater Hospital, the Queensland AI Hub and IntelliHQ are onboard as industry partners.

Cohort has the full event livestream here.


August 2, 2023 By Kathy Kruger

Filed Under: BUSINESS, INVEST, TECHNOLOGY

International MedTech company joins GCHKP ecosystem

With a vision of the Gold Coast as a leading global centre for endovascular R&D and training, neurovascular device company Wallaby-phenox  (Wallaby, phenox) has based its Vice President for international direct markets, including Asia-Pacific, Latin America and the Middle East, in a new office in the Gold Coast Health and Knowledge Precinct.

The US/Chinese/German-operated company will leverage recent investment by Doctors Hal Rice and Laetitia de Villiers in their world-first NeuTex Image-guided surgery and robotics training centre, in partnership with global medical leader Philips, to stage global expansion in treatments for stroke and other conditions.

A 20-year-veteran of the medical device industry with a passion for the life-saving potential of neuro-interventional technologies, Wallaby-phenox’s Kirk Slater has never been more excited at the opportunity to save lives and reduce disability through minimally-invasive endovascular procedures.

And he loves that he can achieve global impact from his adopted home on the Gold Coast.

“The Gold Coast is a great location to access the Asia-Pacific, but the unique value is the opportunity to work closely with NeuTex and doctors Rice and de Villiers, who I’ve known and worked with as leading innovators for 15 years,” Kirk says.

Originally from South Africa and having worked for both major and smaller MedTech companies in Australia and New Zealand, Kirk is relishing a return to a smaller company with a growing global reach, accelerated when Wallaby Medical, jointly based in the US and China, acquired German neuro-interventional leader phenox in April 2022.

Their portfolio of medical products now includes catheters, coil systems and flow modulation devices, with 5 R&D centers, 3 production bases, over 700 employees worldwide, and more than 350 global patents granted or pending.

“I like building things and being an underdog,” Kirk says.

“In this role, I have the opportunity to be creative and disruptive, and we need innovation if we are to substantially increase endovascular treatment for stroke over the prevailing protocol of clot-busting drugs, which unfortunately leaves some patients clinically excluded from treatment due to time-sensitivity and underlying conditions.”

Kirk stresses that it’s not a battle of drugs vs devices, but an opportunity to continue to evolve endovascular treatments to achieve broader reach by taking a ‘value-based’ healthcare approach.

“When considering treatment options and costs we want to be evaluating what one ‘quality life year’ is worth to the individual and society – stroke unfortunately still causes a lot of disability,” he says.

 

Specialist training fellows in the NeuTex Image-Guided Therapy Surgery and Robotics Training Centre which opened in May 2023

The neurovascular field has led the way in minimally-invasive image-guided interventions, treating strokes and brain aneurysms by feeding tiny devices such as coils and stents into the brain through fine catheters to repair blockages. The future includes treating patients with neurodegenerative conditions using implantable devices.

Kirk with Wallaby-phenox President Global Commercial Peter Cooke (second from right) with BirdDog and Remedi CEO Dan Miall (left) and Medical Innovation Manager Ben Wills (right)

Beyond conditions in the brain, innovation in cardiovascular, peripheral vascular, spinal and renal treatments using catheters and devices present the opportunity to help many more patients.

“The Neurovascular device market is worth $4-5 billion worldwide, compared to the $60 billion global cardiology market, which shows the order of magnitude of patients that innovation in cardiology could serve.”

Kirk plans to grow a team of 6 based at Cohort Innovation Space, with the same number based across Australia within the next few years.

He’ll concentrate on opening up the Indian market and the broader Asia-Pacific region, as well as direct entry into Latin America – a big brief that requires long days and nights to accommodate different timezones.

Equally, he’s focused on what comes next – innovation in catheter designs that are thinner and more durable – and next-generation training, partnering with NeuTex and their technology partner BirdDog, an Australian ASX-listed company that provides high-fidelity video capture and software to enable remote proctoring.

“We want to be the first neurovascular device company to deliver truly global workshops via high-quality video links that provide realistic experiences for trainees in multiple locations at once,” Kirk says.

“One day we hope that will extend to using robotics to enable cross-border procedures, where expert clinicians can collaborate to treat complex cases.”

June 22, 2023 By Kathy Kruger

Filed Under: BUSINESS, HEALTH, INVEST, LIVE, PROJECTS

Work commences on premium GCHKP development RDX

(L-R) Debbie McNamara, General Manager EDQ, Craig Mitchell President Northwest Healthcare Properties REIT, Hon Stirling Hinchcliffe, Queensland Minister for Tourism, Innovation and Sport, Dr Hal Rice, Tim Baker, CEO City of Gold Coast

Work has commenced on RDX Lumina, a placemaking Gold Coast Health and Knowledge development by Northwest Healthcare Properties, Australia’s largest healthcare real estate owner.

The Hon. Stirling Hinchliffe, Minister for Tourism, Innovation and Sport yesterday turned sod on the $154m project at a ceremony on the RDX site in the heart of the Precinct’s Lumina commercial district, alongside Northwest President and Regional CEO Craig Mitchell.

RDX is a premium eight-level health and innovation facility fitted for research, biotech, clinical and education functions.

At the ceremony, Mr Hinchcliffe said he expects life sciences work done under RDX’s roof will produce ”innovations that will deliver to the world”.

“We’ll see [RDX] making a massive difference to the way this Precinct delivers on its promise to be a real world-leading cutting edge health and knowledge precinct,” he says. 

Northwest President and Regional CEO Craig Mitchell says the building’s position in the heart of GCHKP will create significant collaboration opportunities for RDX tenants.

“By creating a world-class facility to attract the best people in the industry and encourage further investment in research, development and training, we hope to make a substantial commitment to the broader healthcare industry into the future, in Queensland and beyond.” 

“The GCHKP location represents an added opportunity to collaborate with Griffith University researchers, other clinicians and industry partners.”

Mr Mitchell says RDX will be used for cutting edge life sciences work such as neuroendovascular radiology, interventional cardiology innovation and training, rehabilitation inpatient and outpatient clinical services, human clinical trials, research and virtual care via robotic technologies.

“It’s very important to build the ecosystem where you’ve got the private sector, the public sector, PhD students and researchers—an ecosystem looking at how you take research all the way through to the patient, the whole journey from the lab to bed.” 

After the sod turning, the official party attended the Precinct’s new Neutex Image-Guided Surgical Training and Technologies Centre for a tour conducted by co-founder Dr Hal Rice.

Neutex, a committed tenant of RDX, is working until construction is complete from commercial Precinct space provided by Northwest to deliver world-leading training to specialists from across the Asia Pacific using the latest Philips Image-guided therapy system and technologies. 

The 6-Star Green Star RDX is designed as an all-electric, carbon-neutral building and due for completion mid-2025. 

With Evans Long’s $80m eight-storey development Proxima due for completion 2024, RDX is part of a construction boom in the GCHKP, driven by nearly $250m of private investment. 

June 1, 2023 By Gemma Bull

  • « Go to Previous Page
  • Page 1
  • Interim pages omitted …
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Interim pages omitted …
  • Page 33
  • Go to Next Page »

Primary Sidebar

Recent Posts

  • From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort
  • A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast
  • Clinician Entrepreneurship Program wraps as a big success
  • 2025 International Women’s Day
  • International Women’s Day event 2025
  • Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research
  • INVEST-FEST accelerates founder funding
  • Student innovation incubator set to launch in 2025
  • World-first clinical trial for treating spinal cord injury
  • Australian-designed Total Artificial Heart amongst The Australian’s Top 100

Archives

  • April 2025
  • March 2025
  • February 2025
  • November 2024
  • October 2024
  • September 2024
  • July 2024
  • May 2024
  • April 2024
  • January 2024
  • December 2023
  • October 2023
  • September 2023
  • August 2023
  • June 2023
  • May 2023
  • April 2023
  • March 2023
  • February 2023
  • October 2022
  • August 2022
  • July 2022
  • May 2022
  • March 2022
  • February 2022
  • November 2021
  • October 2021
  • August 2021
  • July 2021
  • May 2021
  • April 2021
  • March 2021
  • February 2021
  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • March 2020
  • February 2020
  • December 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • January 2019
  • December 2018
  • October 2018
  • August 2018

Subscribe to our newsletter and we’ll update you on all that’s new in our Precinct.

Latest News

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort image

From Research to Reality: GCHKP Talent Leads the LuminaX 2025 Cohort

Read More >

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast image

A New Era of Health and Tech Innovation: HATRIC to Transform the Gold Coast

Read More >

Clinician Entrepreneurship Program wraps as a big success image

Clinician Entrepreneurship Program wraps as a big success

Read More >

2025 International Women's Day image

2025 International Women's Day

Read More >

International Women's Day event 2025 image

International Women's Day event 2025

Read More >

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research image

Associate Prof Lara Herrero leading the fight against mosquito-borne diseases and advancing medical research

Read More >

Before Footer

Search

Asia-Pacific’s emerging health and innovation hub, the 200-hectare Gold Coast Health & Knowledge Precinct (GCHKP) is a unique global business location for high-tech industry development, research collaboration and jobs of the future.

  • Home
  • About Us
  • Precinct Map
  • News
  • Do Business
  • Work & Study
  • Partners
  • Projects
  • Research
  • Contact Us
  • Privacy Policy
  • Sitemap
  • Subscribe
  • Facebook
  • LinkedIn
  • YouTube

© 2025 Gold Coast Health and Knowledge Precinct. All rights reserved.

Designed and Developed by Stead Lane